Metraipolis › archive › dc_b22acbb47373
Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy — Europe PMC PMID:41616036
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41616036
- DOI
- 10.1371/journal.pmed.1004930
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T10:00:58.008Z
- SHA-256 of the archived text
67d71e1a609c51eff14685ea1a6f9360f0344b66636a3cd4c38edefc41803070- Stable URL of this page
https://metraipolis.com/documento/dc_b22acbb47373
How to cite
Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy — Europe PMC PMID:41616036 — Europe PMC (en), https://europepmc.org/article/MED/41616036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b22acbb47373 (Metraipolis archive dc_b22acbb47373, sha256 67d71e1a609c51eff14685ea1a6f9360f0344b66636a3cd4c38edefc41803070)
BibTeX
@misc{dcb22acbb47373,
title = {Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy — Europe PMC PMID:41616036},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41616036},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b22acbb47373; sha256 67d71e1a609c51eff14685ea1a6f9360f0344b66636a3cd4c38edefc41803070},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41616036. Agents can read the archived copy with the MCP tool read_document.